Skip to main content
Hit enter to search or ESC to close
Close Search
search
Menu
Home
About Us
About Us
To become most Valued & Trusted partner for access to medicines.
Our Mission
Menu
Vision and Mission
Management Team
Partnership
Corporate Values
Gallery
How can we help
How can we help
Any question or remarks? Just write us a message!
Contact Us
Menu
Patients & Healthcare Professionals
Pharmaceutical Companies
Services
Services
To become most Valued & Trusted partner for access to medicines.
Services Overview
Services Menu
RLD Supplies
Clinical Trial Material supplies
Named Patient Program
Rare Diseases Products Access
Generic Medicine Supply
Global footprints
Global footprints
To become most Valued & Trusted partner for access to medicines.
Menu
Global Network Offices
Warehousing and Logistics
All Resources
twitter
facebook
linkedin
youtube
instagram
Contact Us
search
All Resources
All Resources
Events
Latest Approval
News
Filter
All
All Resources
Events
Latest Approval
News
Updates
All Resources
Updates
Elevate Your Pharmaceutical Supply Chain: Discover Italy’s Regulatory Framework for Sourcing High-Quality RLDs and Biologics From Italy with Invimeds
Introduction Italy is a key player in the pharmaceutical industry, with a…
Read More
All Resources
Updates
Tinefcon: A Natural Solution for Managing Psoriasis
Psoriasis is a chronic autoimmune skin condition impacting millions worldwide, leading to…
Read More
All Resources
Updates
The Benefits of Choosing Natural Treatments for Psoriasis
Introduction Psoriasis is a chronic autoimmune skin condition affecting millions globally. While…
Read More
All Resources
Updates
Managing Psoriasis: Coping Strategies, Dietary Tips, and Emotional Support
Introduction Psoriasis is a chronic autoimmune skin condition that significantly impacts daily…
Read More
All Resources
Updates
Invimeds Facilitates Reliable RLD Sourcing from Brazil: Ensuring Quality and Compliance in Pharmaceutical Development
Introduction Brazil is the third-largest pharmaceutical market in America and holds the…
Read More
All Resources
News
FDA Approves Bkemv: The First Interchangeable Biosimilar to Soliris for Treating Rare Diseases
The U.S. Food and Drug Administration (FDA) has approved Bkemv (eculizumab-aeeb) as…
Read More
All Resources
Updates
Multiple Sclerosis: Prevalence, Diagnosis, Treatment, and Market Growth | World MS Day 2024-2025
Introduction World Multiple Sclerosis Day occurs annually on May 30th, uniting communities…
Read More
All Resources
News
Biocon Biologics Gains FDA Approval for Yesafili™: A Milestone in Ophthalmology Treatment
Introduction: Biocon Biologics Ltd (BBL), a leading global biosimilars company and subsidiary…
Read More
All Resources
Updates
Unlock Growth Potential by Sourcing Biologics or RLDs from France with Invimeds: Market Insights and Regulatory Expertise
Introduction: France stands as a prominent hub for pharmaceutical innovation and production,…
Read More
Filter
Events
All Resources
Events
Comprehensive Guide to World Thalassemia Day: Understanding, Treatment, Financial Aid and Market Trends
Introduction World Thalassemia Day, commemorated annually on May 8th, stands as a…
Read More
All Resources
Events
Empowering Global Asthma Awareness: A Comprehensive Guide to World Asthma Day and Asthma Management
Introduction Every year, on the first Tuesday of May, World Asthma Day…
Read More
All Resources
Events
World Leprosy Day 2024: Join the Movement to Beat Leprosy
Introduction Every year, World Leprosy Day is observed on the final Sunday…
Read More
All Resources
Events
Cervical Health Awareness Month: Theme, History, Statistics
Introduction Cervical Health Awareness Month is marked in January, a time dedicated…
Read More
All Resources
Events
International Mind-Body Wellness Day
On January 3rd, we celebrate International Mind-Body Wellness Day, a time dedicated…
Read More
All Resources
Events
Universal Health Coverage (UHC) Day 2023
Universal Health Coverage (UHC) Day, is observed annually on December 12th. This…
Read More
All Resources
Events
Navigating the Future of the Healthcare Industry: Insights into CPhI Europe
The healthcare sector has been brought to the forefront of global innovation…
Read More
All Resources
Events
INVIMEDS HEALTH TO PRESENT INNOVATIONS AT EXPOPHARM 2023, DUSSELDORF
A prominent role player in the pharmaceutical and healthcare industry, InviMeds Health…
Read More
All Resources
Events
A Successful Collaboration: InviMeds Health Shines at ARAB HEALTH 2023
InviMeds Health a leading healthcare company is proud to announce its successful…
Read More
Filter
Latest Approval
All Resources
Latest Approval
FDA approves Sandoz Tyruko for the treatment of multiple sclerosis
Tyruko (natalizumab-site), a natalizumab biosimilar, has been authorized by the FDA as…
Read More
All Resources
Latest Approval
FDA Approves Breakthrough Treatment for CHAPLE Disease
FDA has recently approved the first-ever treatment for pancreatitis, a protein-loss form…
Read More
Filter
News
All Resources
News
FDA Approves Bkemv: The First Interchangeable Biosimilar to Soliris for Treating Rare Diseases
The U.S. Food and Drug Administration (FDA) has approved Bkemv (eculizumab-aeeb) as…
Read More
All Resources
News
Biocon Biologics Gains FDA Approval for Yesafili™: A Milestone in Ophthalmology Treatment
Introduction: Biocon Biologics Ltd (BBL), a leading global biosimilars company and subsidiary…
Read More
All Resources
News
Unveiling the Paradox: Why Korean Oncologists Favor Originators Despite Biosimilar Equivalence
Introduction: In the dynamic landscape of oncology treatment, biosimilars have emerged as…
Read More
All Resources
News
AstraZeneca’s Acknowledgment of Rare Thrombosis Side Effects in Covishield Vaccines
Introduction: In the global fight against the COVID-19 pandemic, vaccines have become…
Read More
News
Updates
FDA Grants Approval To Avzivi, Marking The Fifth Biosimilar To Avastin
The FDA has approved Avzivi (bevacizumab-tnjn), the fifth biosimilar of bevacizumab developed…
Read More
News
FDA Approves Enzalutamide for Non-Metastatic Castration-Sensitive Prostate Cancer: A Game-Changer in Treatment
We're thrilled to share groundbreaking news in the realm of oncology: On…
Read More
All Resources
News
Fda approves wezlana as an interchangeable biosimilar to stelara for Multiple Inflammatory Diseases
The US Food and Drug Administration (FDA) has approved Wezlana (ustekinumab-auub) as…
Read More
All Resources
News
Horizon Therapeutics takes the rare disease reputation crown
Another wreath has been added to Horizon Therapeutics' pre-takeover victory lap. Months…
Read More
Close Menu
Home
About Us
About Us
To become most Valued & Trusted partner for access to medicines.
Our Mission
Menu
Vision and Mission
Management Team
Partnership
Corporate Values
Gallery
How can we help
How can we help
Any question or remarks? Just write us a message!
Contact Us
Menu
Patients & Healthcare Professionals
Pharmaceutical Companies
Services
Services
To become most Valued & Trusted partner for access to medicines.
Services Overview
Services Menu
RLD Supplies
Clinical Trial Material supplies
Named Patient Program
Rare Diseases Products Access
Generic Medicine Supply
Global footprints
Global footprints
To become most Valued & Trusted partner for access to medicines.
Menu
Global Network Offices
Warehousing and Logistics
All Resources
Contact Us
+91
8218652402
+91 1204340964
enquiry@invimeds.com
twitter
facebook
linkedin
youtube
instagram